Imatinib restores expression of CD62L in BCR-ABL-positive cells.
about
BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cellsChanges in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells.It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib.Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach
P2860
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@en
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@nl
type
label
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@en
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@nl
prefLabel
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@en
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@nl
P2093
P2860
P356
P1476
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
@en
P2093
Fruehauf S
Gschaidmeier H
P2860
P304
P356
10.1189/JLB.1002507
P577
2003-05-01T00:00:00Z